165 related articles for article (PubMed ID: 15963548)
1. Differential expression of LFA-3, Fas and MHC Class I on Ad5- and Ad12-transformed human cells and their susceptibility to lymphokine-activated killer (LAK) cells.
Bottley G; Cook GP; Meade JL; Holt JR; Hoeben RC; Blair GE
Virology; 2005 Aug; 338(2):297-308. PubMed ID: 15963548
[TBL] [Abstract][Full Text] [Related]
2. E1A oncogene of adenovirus-12 mediates trans-repression of MHC class I transcription in Ad5/Ad12 somatic hybrid transformed cells.
Ge R; Liu X; Ricciardi RP
Virology; 1994 Sep; 203(2):389-92. PubMed ID: 8053163
[TBL] [Abstract][Full Text] [Related]
3. Identification of adenovirus E1A regions which affect MHC class I expression and susceptibility to cytotoxic T lymphocytes.
Pereira DS; Rosenthal KL; Graham FL
Virology; 1995 Aug; 211(1):268-77. PubMed ID: 7645220
[TBL] [Abstract][Full Text] [Related]
4. Wild-type adenovirus type 5 transforming genes function as transdominant suppressors of oncogenesis in mutant adenovirus type 5 transformed rat embryo fibroblast cells.
Su ZZ; Leon JA; Jiang H; Austin VN; Zimmer SG; Fisher PB
Cancer Res; 1993 Apr; 53(8):1929-38. PubMed ID: 8385576
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of major histocompatibility complex class I expression and susceptibility to natural killer cells in cells transformed with the oncogenic adenovirus 12 are regulated by different E1A domains.
Huvent I; Cousin C; Kiss A; Baroni de Moraes MT; Bernard C; D'Halluin JC
Cancer Detect Prev; 1997; 21(1):12-21. PubMed ID: 9043758
[TBL] [Abstract][Full Text] [Related]
6. Induction of differentiation-regulated transcription factor Oct-6 specifically accompanies major histocompatibility complex class I down-regulation by E1A of oncogenic adenovirus type 12.
Peeper DS; Schouten GJ; Toebes M; Meijer D; Zwart R; van de Woude I; van Schaik H; van der Eb AJ; Zantema A
Cell Growth Differ; 1995 Aug; 6(8):977-84. PubMed ID: 8547226
[TBL] [Abstract][Full Text] [Related]
7. The first exon of Ad12 E1A excluding the transactivation domain mediates differential binding of COUP-TF and NF-kappa B to the MHC class I enhancer in transformed cells.
Kushner DB; Pereira DS; Liu X; Graham FL; Ricciardi RP
Oncogene; 1996 Jan; 12(1):143-51. PubMed ID: 8552385
[TBL] [Abstract][Full Text] [Related]
8. Increased cyclin A and decreased cyclin D levels in adenovirus 5 E1A-transformed rodent cell lines.
Buchou T; Kranenburg O; van Dam H; Roelen D; Zantema A; Hall FL; van der Eb A
Oncogene; 1993 Jul; 8(7):1765-73. PubMed ID: 8510923
[TBL] [Abstract][Full Text] [Related]
9. An ovine adenovirus vector lacks transforming ability in cells that are transformed by AD5 E1A/B sequences.
Xu ZZ; Nevels M; MacAvoy ES; Lockett LJ; Curiel D; Dobner T; Both GW
Virology; 2000 Apr; 270(1):162-72. PubMed ID: 10772988
[TBL] [Abstract][Full Text] [Related]
10. Adenovirus E1A inhibits IFN-induced resistance to cytolysis by natural killer cells.
Routes JM
J Immunol; 1993 May; 150(10):4315-22. PubMed ID: 7683316
[TBL] [Abstract][Full Text] [Related]
11. Role of LFA-3, ICAM-1, and MHC class I on the sensitivity of human tumor cells to LAK cells.
Gwin JL; Gercel-Taylor C; Taylor DD; Eisenberg B
J Surg Res; 1996 Jan; 60(1):129-36. PubMed ID: 8592403
[TBL] [Abstract][Full Text] [Related]
12. Region E1a of highly oncogenic adenovirus 12 in transformed cells protects against NK but not LAK cytolysis.
Kenyon DJ; Raska K
Virology; 1986 Dec; 155(2):644-54. PubMed ID: 2947382
[TBL] [Abstract][Full Text] [Related]
13. E1A products of adenoviruses reduce the expression of cellular proliferation-associated genes.
Timmers HT; De Wit D; Bos JL; Van der Eb AJ
Oncogene Res; 1988; 3(1):67-76. PubMed ID: 2974528
[TBL] [Abstract][Full Text] [Related]
14. E1A oncogene expression in target cells induces cytolytic susceptibility at a post-recognition stage in the interaction with killer lymphocytes.
Cook JL; Potter TA; Bellgrau D; Routes BA
Oncogene; 1996 Aug; 13(4):833-42. PubMed ID: 8761305
[TBL] [Abstract][Full Text] [Related]
15. Tumorigenicity of adenovirus-transformed cells: region E1A of adenovirus 12 confers resistance to natural killer cells.
Sawada Y; Föhring B; Shenk TE; Raska K
Virology; 1985 Dec; 147(2):413-21. PubMed ID: 3878030
[TBL] [Abstract][Full Text] [Related]
16. Growth suppression and toxicity induced by caffeic acid phenethyl ester (CAPE) in type 5 adenovirus-transformed rat embryo cells correlate directly with transformation progression.
Su ZZ; Lin J; Grunberger D; Fisher PB
Cancer Res; 1994 Apr; 54(7):1865-70. PubMed ID: 7511055
[TBL] [Abstract][Full Text] [Related]
17. E1A oncogene expression level in sarcoma cells: an independent determinant of cytolytic susceptibility and tumor rejection.
Cook JL; Wilson BA; Wolf LA; Walker TA
Oncogene; 1993 Mar; 8(3):625-35. PubMed ID: 8437846
[TBL] [Abstract][Full Text] [Related]
18. Consequences of disruption of the interaction between p53 and the larger adenovirus early region 1B protein in adenovirus E1 transformed human cells.
Hutton FG; Turnell AS; Gallimore PH; Grand RJ
Oncogene; 2000 Jan; 19(3):452-62. PubMed ID: 10656694
[TBL] [Abstract][Full Text] [Related]
19. A lymphokine-activated killer (LAK)-resistant cell line, and low expression of adhesion molecules LFA-3 and VCAM-1 on its cell surface.
Komatsu F; Kajiwara M
Oncol Res; 1998; 10(5):263-9. PubMed ID: 9802061
[TBL] [Abstract][Full Text] [Related]
20. Correlation of class I MHC antigen levels on some human tumor cell lines with susceptibility to LAK cells and performance in cold target inhibition assays.
Haridas V; Saxena RK
Cell Immunol; 1995 Apr; 161(2):256-61. PubMed ID: 7697736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
